| 000 | 01688 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517214437.0 | ||
| 264 | 0 | _c20190520 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a2210-7711 | ||
| 024 | 7 |
_a10.1007/s11096-018-0649-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlimano, Florian | |
| 245 | 0 | 0 |
_aOlanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacy _cOct 2018 |
||
| 300 |
_a1265-1271 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiemetics _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAprepitant _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Resistance _xdrug effects |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aOlanzapine _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSerotonin Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNetzer, Florence | |
| 700 | 1 | _aBorget, Isabelle | |
| 700 | 1 | _aLemare, François | |
| 700 | 1 | _aBesse, Benjamin | |
| 773 | 0 |
_tInternational journal of clinical pharmacy _gvol. 40 _gno. 5 _gp. 1265-1271 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11096-018-0649-1 _zAvailable from publisher's website |
| 999 |
_c28375162 _d28375162 |
||